Skip to main content

PAINWeek 2023 Main banner

Icon Legend

This session is not in your agenda.

This session is in your agenda. Click to remove it

Back

Robert Vann, PhD

Director, Medical Science Liaisons
Impel Pharmaceuticals
Seattle, Washington

Disclosure information not submitted.

Presentation(s):

Assessment of the Potential for Drug–Drug Interactions Between INP104 (Trudhesa®) and Gepants for Migraine Management Using a Model-based Approach
POSTER ABSTRACT
Real-world assessment of concomitant migraine medication use in patients using INP104 (Trudhesa®) in the United States
POSTER ABSTRACT